UnitedHealth Group Inc (UNH) Position Reduced by Kays Financial Advisory Corp ADV
Kays Financial Advisory Corp ADV lessened its stake in UnitedHealth Group Inc (NYSE:UNH) by 4.6% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 6,130 shares of the healthcare conglomerate’s stock after selling 294 shares during the period. Kays Financial Advisory Corp ADV’s holdings in UnitedHealth Group were worth $1,631,000 as of its most recent SEC filing.
Other hedge funds also recently bought and sold shares of the company. FNY Investment Advisers LLC bought a new stake in shares of UnitedHealth Group in the 3rd quarter valued at about $106,000. Welch Group LLC bought a new stake in shares of UnitedHealth Group in the 2nd quarter valued at about $106,000. Blue Chip Partners Inc. bought a new stake in shares of UnitedHealth Group in the 2nd quarter valued at about $107,000. Polaris Greystone Financial Group LLC bought a new stake in shares of UnitedHealth Group in the 3rd quarter valued at about $120,000. Finally, Fort L.P. bought a new stake in shares of UnitedHealth Group in the 2nd quarter valued at about $119,000. 85.43% of the stock is currently owned by institutional investors.
Shares of UNH stock opened at $276.55 on Friday. The company has a debt-to-equity ratio of 0.61, a quick ratio of 0.75 and a current ratio of 0.69. The stock has a market cap of $253.65 billion, a PE ratio of 27.46, a PEG ratio of 1.52 and a beta of 0.78. UnitedHealth Group Inc has a twelve month low of $208.48 and a twelve month high of $278.00.
The company also recently declared a quarterly dividend, which will be paid on Thursday, December 13th. Stockholders of record on Monday, December 3rd will be given a dividend of $0.90 per share. This represents a $3.60 annualized dividend and a dividend yield of 1.30%. UnitedHealth Group’s payout ratio is 35.75%.
UNH has been the subject of a number of recent analyst reports. BMO Capital Markets lifted their target price on shares of UnitedHealth Group to $310.00 and gave the stock an “outperform” rating in a research note on Thursday, October 18th. Oppenheimer lifted their target price on shares of UnitedHealth Group from $276.00 to $295.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 17th. Zacks Investment Research upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $287.00 target price for the company in a research note on Sunday, July 15th. Piper Jaffray Companies lifted their target price on shares of UnitedHealth Group to $300.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 17th. Finally, Royal Bank of Canada lifted their target price on shares of UnitedHealth Group from $282.00 to $284.00 and gave the stock a “$255.42” rating in a research note on Wednesday, July 18th. One equities research analyst has rated the stock with a hold rating, twenty-two have assigned a buy rating and one has issued a strong buy rating to the company. The company presently has an average rating of “Buy” and a consensus target price of $289.41.
In other news, EVP D Ellen Wilson sold 15,393 shares of the business’s stock in a transaction dated Friday, August 24th. The shares were sold at an average price of $264.29, for a total transaction of $4,068,215.97. Following the transaction, the executive vice president now owns 66,402 shares of the company’s stock, valued at approximately $17,549,384.58. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CEO Steven H. Nelson sold 8,142 shares of the business’s stock in a transaction dated Thursday, September 13th. The shares were sold at an average price of $265.00, for a total transaction of $2,157,630.00. Following the transaction, the chief executive officer now directly owns 22,496 shares in the company, valued at approximately $5,961,440. The disclosure for this sale can be found here. In the last three months, insiders have sold 69,568 shares of company stock worth $18,539,877. Corporate insiders own 0.87% of the company’s stock.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Featured Story: Outstanding Shares, Buying and Selling Stocks
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.